The following was submitted to the Journal of Medicinal Chemistry as a mini-perspective for their special issue on AI in drug discovery. I leave it to the reader to judge whether they were right to reject it forthwith.
The breadth of the field of artificial intelligence (AI) in drug discovery …
I was recently invited by OpenEye Scientific to speak at their 19th CUP meeting - a scientific conference focused on challenges of computational modeling in drug discovery. It was my first time back at CUP in 8 years, since I switched fields from computational chemistry into computational …
Drug discovery is a hard business, and like any other hard business, there are a lot of people who’d not only like to improve it, but think they have a clever idea to completely change how it’s done and catapult us into a new world of productivity. It …